WILMINGTON – Biopharmaceutical giant Incyte Corp. announced Monday that it has bought into a new collaboration deal on a monoclonal antibody, paying about $152 million to Massachusetts-based clinical stage company […]
WILMINGTON – Incyte Corp. reported a “disappointing” conclusion Monday to its study of its blockbuster drug Jakafi to fight the effects of COVID-19 in hospitalized patients. The pharmaceutical company headquartered […]
WILIMINGTON – Global biopharmaceutical company Incyte announced April 2 that it was studying whether it could repurpose its blockbuster drug Jakafi to aid in the treatment of COVID-19 patients. The […]
In 1991, CB Research and Development was founded in a 2,000-square-foot facility to synthesize specialized chemical compounds for drug-makers. There were three employees. That same year, Incyte was founded in […]
Incyte Corporation has announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi® (ruxolitinib) for the treatment of steroid-refractory acute GVHD in adult and pediatric patients 12 years […]
© 2023 Delaware Business Times